Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NEOS S&P 500 High Income ETF (SPYI) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance

NEOS S&P 500 High Income ETFTrade
DENTSPLY SIRONA IncTrade

Price performance (Past 24H)

Key statistics

NEOS S&P 500 High Income ETF vs DENTSPLY SIRONA Inc — how do they compare? NEOS S&P 500 High Income ETF trades at $54.09 (market cap $12.51B), while DENTSPLY SIRONA Inc trades at $8.67 (market cap $1.70B). The key difference: NEOS S&P 500 High Income ETF is far larger — about 7.4× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while NEOS S&P 500 High Income ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold NEOS S&P 500 High Income ETF for 57 Days and DENTSPLY SIRONA Inc for 72 Days on average.

SPYIXRAY
Market Cap
$12.51B$1.70B
Volume
2,751,6024,220,050
Sector
Income / Options OverlayHealth
52-Week High
$54.42$14.68
52-Week Low
$47.98$8.52
Typical Hold Time
57 Days72 Days
Enterprise Value
—$3.78B
Dividend Yield
—5.04%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

NEOS S&P 500 High Income ETF

SPYI trades at $54.01, down 0.13% with a bullish technical signal from moving averages. The ETF shows strong institutional interest as a covered-call income vehicle, though recent news highlights concerns about principal erosion from high-yield strategies. Technical indicators show RSI at overbought levels while support and resistance cluster around $54.

The outlook remains mixed with strong income generation potential offset by capital preservation risks. Recent coverage emphasizes the trade-off between high monthly distributions and potential long-term principal decline, requiring careful consideration for retirement income strategies.

DENTSPLY SIRONA Inc

DENTSPLY SIRONA (XRAY) trades at $8.69, near its 52-week low, with bearish technical signals and declining revenue trends. The company reported Q2 2026 earnings beat but faces margin pressure and negative profitability metrics. Recent news highlights institutional stake increases and ongoing restructuring efforts amid challenging dental market conditions.

The stock presents a high-risk opportunity with analyst consensus target of $13.40 suggesting 54% upside potential. However, persistent net losses, declining revenue, and bearish technical indicators warrant caution. Recovery depends on successful execution of turnaround initiatives and market share stabilization in competitive dental equipment sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SPYI
67% Buy33% Sell
Avg holding period · 57 Days
XRAY

No sentiment data available yet.

About NEOS S&P 500 High Income ETF

SPYI is an actively managed ETF designed to generate high monthly income through a data-driven call option strategy on the S&P 500 Index. Unlike traditional covered call funds that often forfeit significant upside, SPYI utilizes a 'call spread' approach—selling near-the-money calls while buying out-of-the-money calls—to capture a portion of equity appreciation in rising markets. It prioritizes tax efficiency by utilizing Section 1256 contracts and tax-loss harvesting to provide investors with high-yield monthly distributions.

Read more on SPYI →

About DENTSPLY SIRONA Inc

Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters

Read more on XRAY →